News

Obama: Insufficient data to fast-track Ebola drug

Obama: Insufficient data to fast-track Ebola drug

EBOLA OUTBREAK: U.S. President Barack Obama delivers remarks at the first Leaders Session of the U.S.-Africa Leaders Summit at the State Department in Washington, Aug. 6. Photo: Reuters/Larry Downing

WASHINGTON (Reuters) – President Barack Obama said on Wednesday he lacks enough information to green-light a promising drug to treat the deadly Ebola virus and that the initial response should focus on public health measures to contain the outbreak.

“We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful,” the president said at a media conference. “The Ebola virus both currently and in the past is controllable if you have a strong public health infrastructure in place.”

Public health officials should do all they can to contain the outbreak, and during the course of that process, authorities can assess whether new drugs or treatments can be effective, he said.

“We’re focusing on the public health approach right now, but I will continue to seek information about what we’re learning about these drugs going forward,” he said.

(Reporting By Mark Felsenthal; Editing by Sandra Maler)

Recent Headlines

in Sports

NFL ‘on track’ to field London team

nfl

The NFL plans to field a team in London and could have a franchise there by 2022.

in National

Travelers quarantined as U.S. steps up Ebola checks

ebola

The U.S. has started new restrictions on those coming from the countries hardest hit by the deadly virus.

in Lifestyle

Online harassment commonplace among adults

ComputerHands_620

It's something anyone who has ever been online knows: the Internet can be a rough place.

in National

Sears to close stores, lay off thousands of employees

sears

Sears will lay off at least 5,457 employees and close more than 100 stores, many before Christmas.

in Sports

Thursday’s Sports Minute

sanfran

A look at the big sports stories you'll be talking about today, Thursday, Oct. 23.